Cargando…
Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease
The modified 2-tier testing algorithm (MTTT) for Lyme disease (LD) has been approved by the US Food and Drug Administration. In this study, we show that the MTTT detected 28% more cases of early infection compared with the standard 2-tier algorithm while retaining high specificity in a region with a...
Autores principales: | Khan, Farhan, Allehebi, Ziyad, Shabi, Yahya, Davis, Ian, LeBlanc, Jason, Lindsay, Robbin, Hatchette, Todd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297310/ https://www.ncbi.nlm.nih.gov/pubmed/35873285 http://dx.doi.org/10.1093/ofid/ofac272 |
Ejemplares similares
-
Lyme Disease, Anaplasmosis, and Babesiosis, Atlantic Canada
por: Allehebi, Ziyad O., et al.
Publicado: (2022) -
Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002–2013
por: Hatchette, Todd F., et al.
Publicado: (2015) -
An ultra-high-density protein microarray for high throughput single-tier serological detection of Lyme disease
por: Jayaraman, Vasanth, et al.
Publicado: (2020) -
861. Development and Clinical Validation of a Custom Modified Two-Tier Testing Algorithm for Serodiagnosis of Lyme Disease
por: Gaylord, Michelle A, et al.
Publicado: (2023) -
Using Serum Specimens for Real-Time PCR-Based Diagnosis of Human Granulocytic Anaplasmosis, Canada
por: Boodman, Carl, et al.
Publicado: (2023)